A Prospective Feasibility Study of Scheduled Screening of Palliative Care Needs and QOL Assessment for Patients with Incurable Advanced Solid Tumor Undergoing Chemotherapy

A Prospective Feasibility Study of Scheduled Screening of Palliative Care Needs and QOL Assessment for Patients with Incurable Advanced Solid Tumor Undergoing Chemotherapy - Scheduled Screening of Palliative Care Needs and QOL Assessment For Patients with Advanced Solid Tumor Undergoing Chemotherapy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012353

Enrollment

Registered

2013-11-20

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumor

Interventions

Periodical screening questionnaire

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Planned to undergo first-line chemotherapy for incurable advanced solid tumor 2) Based on the comfirmed disease and stage, the patient has been fully informed about the treatment by the physician. 3) Able to complete the screening and QOL questionnaire by him- or her-self. 4) Expected to survive for more than 12 weeks. 5) Written informed consent

Exclusion criteria

Exclusion criteria: 1)Concomitant radiotherapy lasting for more than 4 weeks. 2)Chemotherapy planned with interval of 5 weeks or more. 3)Judged inappropriate for participation to the trial by the physician.

Design outcomes

Primary

Measure	Time frame
Completion rate of screening questionnaire	—

Secondary

Measure	Time frame
The trend of questionnaire items, the correlation between items, and quality-adjusted survival	—

Countries

Japan

Contacts

Public ContactKazuhiko Shibata

Comprehensive Cancer Center, Koseiren Takaoka Hospital Medical Oncology

shibata.kazuhiko@gmail.com0766-21-3930

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026